Valvular & structural heart disease

Mitral Regurgitation after TAVR: Sex Differences and Low-Flow Low-Gradient Aortic Stenosis

JACC AdvPublished single-center, observational study

Authors' conclusion

More than half of TAVR patients with moderate or severe MR experience MR improvement post-TAVR. Women and those with severe MR are less likely to have a significant improvement in MR. Patients with LFLG AS and persistent moderate or severe MR have worse survival post-TAVR.

Study context

Population
TAVR patients with severe aortic stenosis (AS) and moderate or greater mitral regurgitation (MR) pre-TAVRconsecutive TAVR patients with severe AS and moderate or greater MR pre-TAVR
Participants
344 patients
Exposure
Patients were stratified by AS subtype
Outcome
Baseline characteristics
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Mean age

81.9 years

Females

48.5%

Low-flow low-gradient (LFLG) AS

45.1%

Observational data: associations, not effects.

Further findings

MR improvement post-TAVR

MR improved by ≥1 grade
62.8%
MR improved to mild or less
52.9%
Similar rates in classic vs LFLG AS

Factors associated with MR improvement to mild or less (multivariable)

Severe (vs moderate) baseline MR, hypertension, and female sex independently associated with lower odds of MR improvement to mild or less
In LFLG AS, female sex and severe MR remained significant predictors of persistent MR
In LFLG AS, higher pre-TAVR aortic valve mean gradient associated with improved MR

Mortality

Residual severe MR was associated with increased mortality, driven by those with LFLG AS
  • Cox proportional hazards models adjusted for clinical and echocardiographic covariates

Original publication

Mitral Regurgitation after TAVR: Sex Differences and Low-Flow Low-Gradient Aortic Stenosis. JACC Adv. Published September 2026. doi:10.1016/j.jacadv.2026.103140

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.